Predicting the Development of Myocardial Depression in Acute Neurological Patients
To Evaluate the Role of Plasma Catecholamine Levels in Predicting the Development of Myocardial Depression in Acute Neurological Patients
Sponsor: Ohio State University
A observational or N/A phase clinical study on Acute Ischemic Stroke and Myocardial Depression, this trial is completed. The trial is conducted by Ohio State University and has accumulated 8 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2022 — May 2024 [monthly]
Recruiting
-
Dec 2021 — Jun 2022 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2019 — Nov 2020 [monthly]
Recruiting
First recorded
Dec 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ohio State University
For direct contact, visit the study record on ClinicalTrials.gov .